Medical/Pharmaceuticals
Daewoong Pharmaceutical Receives World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Daewoong Infion
SEOUL, South Korea, Jan. 8, 2020 /PRNewswire/ -- Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. Daewoong Pharmaceutical Co., Ltd. (CEO Sengho Jeon) announced that Daewoong Infion, the company's joint venture with Infion, an In...
2020-01-08 11:00
1376
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers
* HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies * Study, published in Molecular Cancer Therapeutics, found HMBD-001 to be able to uniquely block HER3 dimerization interface and potently inhibit tumor growth SINGAPORE, Jan. 8, 2020 /PR...
2020-01-08 10:40
857
Rapid Diagnostics Announces Completion of Asset Purchase and New Corporate Strategies
LONDON, Jan. 8, 2020 /PRNewswire/ -- Rapid Diagnostics ML Limited, UK is pleased to announce the return of its Point of Care (PoC) platform, the MiniLab System. Rapid was formed to purchase the assets and Intellectual Property (IP) of the former Enigma Diagnostics, which was liquidated in 2017. ...
2020-01-08 08:00
2152
Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Sintilimab and RNAi in the US
SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, and Sirnaomics Inc. ("Si...
2020-01-08 08:00
9152
Rising Demand for IoT-enabled Pumps to Drive North American PD Pumps Market amid Economic Slowdown
Integration of machine learning, artificial intelligence in pumps to help improve efficiency and reduce maintenance costs, finds Frost & Sullivan SANTA CLARA, California, Jan. 8, 2020 /PRNewswire/ -- Driven by continued investments in the US oil and gas industry, along with increased activity in ...
2020-01-08 06:03
1169
Southstar Drug Gets Ready for the Future with Huawei Wi-Fi 6
MANILLA, Philippines, Jan. 7, 2020 /PRNewswire/ -- Recently, by choosing a wireless Wi-Fi-6 network from Huawei, Southstar Drug is able to operate its business more efficiently and at greater speed, with better access to resources,helping to boost employee productivity. Southstar Drug, a subsidi...
2020-01-08 00:01
1311
LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology
LumaCyte's Radiance platform has broad capabilities aiding in real-time label-free characterization of single-cells giving rise to better understanding of cellular systems and improving process optimization SANTA CLARA, California, Jan. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the...
2020-01-07 20:07
848
Continued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening Technologies
* Grant will fund advanced R&D and incorporation of artificial intelligence (AI) technology to accelerate drug development using Novoheart's bio-engineered human heart chambers and tissues * Potential advancements expected to increase scale and capabilities of Novoheart's MyHeart™ Platform an...
2020-01-07 17:39
2775
Mundipharma Announces Exclusive Deal for Biosolution's CartiLife(R) in South Korea
SINGAPORE, Jan. 7, 2020 /PRNewswire/ -- Mundipharma has announced today that it has sealed an exclusive sales agreement with Biosolution Co., Ltd, a Korea-based leader in cell-based biotechnology, to market and distribute its fourth-generation autologous chondrocyte implantation product, CartiLif...
2020-01-07 11:37
3104
genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models
genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system LYON, France, Jan. 7, 2020 /PRNewswire/ -- genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic ...
2020-01-07 09:00
3004
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab
SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced that the company has entered into a clinical collaboration with a subsidiary of Merck & C...
2020-01-07 08:25
3390
Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review
SALT LAKE CITY and TOKYO, Jan. 7, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that IDCT has p...
2020-01-07 08:00
1438
Inovio Provides Update on Clinical Program Plans for 2020
Inovio to present 2020 program plans at Biotech Showcase 2020 Conference PLYMOUTH MEETING, Pennsylvania, Jan. 6, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that Inovio's President & CEO, Dr. J. Joseph Kim will present a corporate update of the company's clinical progr...
2020-01-06 21:00
2970
12th Consecutive Year Leading United States in Organ Donation for Gift of Life Donor Program
PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- For the 12th consecutive year, Gift
of Life Donor Program is the nation's leading organ procurement organization
(OPO), coordinating the most life-saving organs for transplant among all 58
U.S. OPOs.
2020-01-06 20:00
2837
BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for US-, Canada- and UK-based media - At the planned interim analysis, Phase III JAVELIN Bladder 100 study met the primary endpoint of prolonging overall survival (OS) as a first-line maintenance treatment versus standard of care - BAVENCIO is the first immunotherapy to signifi...
2020-01-06 20:00
4759
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer
SHANGHAI and PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- Antengene Corporation today announced its appointment of Mr.John Chin, MBA, as Chief Business Officer (CBO). He will be responsible for the company's global business development and commercialization, and will report directly to Dr.Jay Mei, ...
2020-01-06 20:00
3676
Dr. Nalini Rajamannan Comments on FDA Congressional Letter to Senate Finance Committee After Kaiser Health News Reveals Access to Exempt FDA Database
SHEBOYGAN, Wis., Jan. 6, 2020 /PRNewswire/ -- Dr. Nalini Rajamannan -- a specialist for patients with valvular heart disease in Most Sacred Heart of Jesus Cardiology,Sheboygan, WI -- confirms today that patients finally may get answers about whether medical devices placed in their bodies are test...
2020-01-06 19:00
1348
Abcam Announces Successful Acquisition of Expedeon's Proteomics and Immunology Business, Enhancing Its Conjugation Capability
- Includes leading protein conjugation technologies and industry brands Lightning-Link® and CaptSure™ - Opportunity to combine Expedeon and Abcam's technologies to create new products to support research and diagnostic development CAMBRIDGE, England, Jan. 6, 2020 /PRNewswire/ -- Abcam plc, a glo...
2020-01-06 15:00
998
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment
GAITHERSBURG, Md. and AMBLER, Pa., Jan. 6, 2020 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, and Tavotek Biotherapeutics, a biotech c...
2020-01-06 09:00
3128
Fountain Medical Appoints Mr. Ling Zhen as the Co-Chairman and Chief Executive Officer
BEIJING and SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- Fountain Medical Development Limited ("Fountain Medical" or "Company"), a clinical stage CRO dedicated to offering high-quality one-stop services to pharmaceutical and medical device clients, announced today that Mr.Ling Zhen, J.D., M.B.A., is ap...
2020-01-02 09:30
6714
Week's Top Stories
Most Reposted
Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 305 media titles]
2024-11-20 13:29Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 304 media titles]
2024-11-21 10:30Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 300 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8683
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5536
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5116
Yingli Solar's Global Product Workshops Launched in Malaysia
2024-11-15 21:40
4753
